Medicine and Dentistry
Antisense
100%
Mitochondrial RNA
97%
Programmed Cell Death
74%
Untranslated RNA
66%
Cancer Cell
66%
Cell Proliferation
65%
Tumor Progression
63%
Malignant Neoplasm
61%
Bladder Cancer
59%
Neoplasm
53%
Tumor Cell
47%
Metastatic Carcinoma
46%
Antisense Oligonucleotide
43%
Tumor Cell Line
41%
Diseases
38%
down Regulation
37%
Survivin
36%
Cell Death
30%
Postoperative Complication
30%
microRNA
29%
In Vitro
29%
Xenograft
28%
Cystectomy
24%
Long Untranslated RNA
24%
Clear Cell Renal Cell Carcinoma
22%
Melanoma
22%
Cell Cycle Progression
22%
Cancer
22%
Adrenalectomy
16%
Chylous Ascites
16%
Fistula
16%
Surgical Anastomosis
16%
Prostatectomy
16%
Peroperative Complication
16%
Partial Nephrectomy
16%
Retroperitoneal Lymph Node Dissection
16%
Pelvis
16%
Urinary Tract Cancer
16%
Kidney Carcinoma
16%
Resuscitation
16%
Carcinogenicity
16%
Cancer Therapy
16%
Crush Syndrome
16%
Cell Cycle Arrest
16%
Cancer Inhibition
16%
Breast Cancer
16%
Cytotoxic T-Cell
16%
Cutaneous Melanoma
16%
Cell Cycle Checkpoint
16%
Urinary System
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
96%
Neoplasm
68%
Mitochondrial RNA
62%
Bladder Cancer
53%
Untranslated RNA
46%
Tumor Growth
33%
Disease
30%
Antisense Oligonucleotide
26%
Kidney Cancer
26%
Survivin
22%
Caspase
20%
Liver Cell Carcinoma
19%
Long Untranslated RNA
19%
Trypanosoma Cruzi
16%
Biodistribution
16%
Central Nervous System Tumor
16%
Octanol
16%
Kidney Carcinoma
16%
Metastasis
16%
Chalcone
16%
Immunotherapy
16%
Blood-Brain Barrier
16%
Urogenital Tract Cancer
16%
microRNA
11%
Anticarcinogen
11%
Nerve Cell Adhesion Molecule
8%
Lipophilicity
8%
Parallel Artificial Membrane Permeability Assay
8%
Central Nervous System Cancer
8%
IC50
8%
Pharmacokinetics
8%
Messenger RNA
7%
Mycobacterium Bovis BCG
6%
Carcinoma in Situ
6%
Normal Human
6%
Cancer Growth
6%
Chalcone Derivative
6%
Reactive Oxygen Metabolite
6%
Chagas Disease
5%
P Cadherin
5%
Metastasis Inhibition
5%
Renal Cell Carcinoma
5%
Biochemistry, Genetics and Molecular Biology
Antisense
91%
Non-Coding RNA
63%
Cancer Cell
60%
Downregulation
52%
Cell Proliferation
45%
Tumor Progression
33%
Mitochondrial RNA
31%
Cell Death
29%
Survivin
26%
Long Non-Coding RNA
26%
Oligonucleotide
20%
Cell Cycle Progression
19%
Cell Cycle Arrest
16%
Growth Inhibition
16%
Fluorescence in Situ Hybridization
16%
Human Papillomavirus Type 18
16%
Keratinocyte
16%
Cell Cycle Checkpoint
16%
Apoptosis
15%
MicroRNA
13%
Inhibitor of Apoptosis
12%
Tumor Suppressor Protein
8%
Messenger RNA
8%
Cyclin B1
8%
Urine Sampling
8%
Cyclin D1
8%
Cell Cycle Regulation
7%
Mitochondrial Membrane Potential
6%
Dicer
5%
Malignant Transformation
5%
Luciferase
5%
Stem-Loop
5%
Upregulation
5%
Carcinogenesis
5%
Human Papillomavirus Type 16
5%
Lifespan
5%